The stock of ICU Medical, Inc. (NASDAQ:ICUI) is now priced at $190.93 and the shares are -0.03 points down or -0.02% lower compared to its previous closing price of $190.96. The stock had 81410 contracts set over the past session. ICUI shares’ daily volume is compared to its average trading volume at 168266 shares. However, it has a float of 19.37 million and although its performance was 5.47% over the week, it’s one to watch. Analysts have given the ICUI stock a yearly average price target of $219 per share. It means the stock’s upside potential is 14.7% with the ICUI share price recently placing at $188.25 to $191.21. However, some brokerage firms have priced the stock below the average, including one that has called $199.
The shorts are climbing into the ICU Medical, Inc. stock, with the latest data on short interest released on June 30, 2020, showing that short interest numbers in the ICUI shares have risen. Short interest in the stock represents just 1.59% of its float, but the volume has raised by 44526. The volume of shorted shares rised to 308257 from 263731 shares over the last two weeks. The average intraday trading volume has been 169414 shares, which means that days to cover moved to roughly 1.819549.
In the last trading session, ICU Medical, Inc. (NASDAQ:ICUI) raised by $7.46 over the week and gained $11.93 on its 20-day. The stock’s high in the recent session is lower when compared to its 52-week high of $259.72. The stock recorded its established 52-week high on 08/01/19.
Since 10/16/19, the stock has traded to a low of $148.89 at 28.24%, an encouraging piece of data likely to interest most investors out to exploit the stock’s recent surge. The stock has a beta allocation of 0.53. Being above 1 means that the stock’s volatility is higher than the market and traders are keenly watching it.
Looking at current readings, ICU Medical, Inc.’s two-week RSI is 58.25. This suggests that the stock is neutral at the moment and that ICUI shares’ price movement remains stable. The stochastic readings are equally revealing at 88.13% meaning the ICUI share price is currently in oversold territory.
The technical chart shows that the ICUI stock will likely settle at between $192.03 and $193.1 per share. However, if the stock dips below $189.07, then its market would become much weaker. Any downside could see the stock price sliding to levels as low as $187.18.
Currently, the stock is trading in the green of MACD, with a reading of 3.88. Investors always pay attention to any move above or below the zero-line, mainly because the indicator points to the position of the stock’s short-term average relative to its long-term measure. A MACD -a reading above the zero line means that the short-term is above the long-term average. This scenario implies that there is an upward momentum. The opposite is true when the MACD falls below the zero-line.
Analysts at CJS Securities raised their recommendation for ICUI from Market Perform to Market Outperform in March 31 review. KeyBanc Capital Markets analysts upgraded their recommendation of the stock from Sector Weight to Overweight while keeping its target price at $206 in a flash note released to investors on March 18. Raymond James seeing the stock struggling downgraded it from Strong Buy to Outperform on August 08.
The average rating for the ICUI equity is 2 and is currently gathering a bullish momentum. Of 3 analysts tracking ICU Medical, Inc. polled by Reuters, 0 rated ICUI as a hold. The remaining 3 analysts were split evenly. However, the split wasn’t equal as a majority (3) rated it as a buy or strong buy. 0 analyst advised investors against buying the stock or to sell if they own any of the stock.
Elsewhere, the ICUI stock price is 25.08X ahead of its 12-month Consensus earnings per share estimates. The stocks P/S ratio currently stands at 47.4below the group’s average of 60.2. ICU Medical, Inc. has its P/E ratio at 2.9, which means that the stock is currently trading at a discount relative to the 5.4 industry average.
Zacks Consensus Estimate forecasts that the current-quarter revenues for ICU Medical, Inc. (NASDAQ:ICUI) will decrease by about -99.92%, which will see them reach $276.7 million. The company’s full-year revenues are, however, expected to diminish by about -7.09%, down from $1270 million to $1180 million. ICUI’s expected adjusted earnings should drop almost -37.69% to end up at $1.24 per share, while for the fiscal year, analysts project the company’s earnings to drop by about -24.26% to record $6.18/share.